Related Experiment Video
Updated: Mar 17, 2026

Author Spotlight: Streamlining Rice Breeding with CRISPR/Cas for Obtaining Optimal Phenotypic and Agronomic Traits
Published on: January 3, 2025
['Red yeast rice' as a cholesterol-lowering substance?Caution is warranted]
J R B J Brouwers1, J E Roeters van Lennep, A H E M Maas
1Rijksuniversiteit Groningen, Unit PharmacoTherapie-Epidemiology & Economics (FTEE), Groningen.
Red yeast rice (RYR), a cholesterol-lowering supplement, contains monacolin K. Consumers should choose reputable brands and be aware of potential risks and interactions, especially during pregnancy.
Area of Science:
- Nutritional Science
- Pharmacology
- Public Health
Background:
- Red yeast rice (RYR), also known as red fermented rice, is widely promoted in non-medical literature for its cholesterol-lowering properties.
- RYR contains monacolin K, a naturally occurring statin, which is responsible for its lipid-lowering effects.
- Despite its popularity, concerns exist regarding product quality, dosage consistency, and potential health risks.
Purpose of the Study:
- To evaluate the current recommendations and risks associated with red yeast rice (RYR) consumption.
- To highlight the importance of product quality and regulatory oversight for RYR supplements.
- To inform healthcare professionals and consumers about safe usage guidelines for RYR.
Main Methods:
- Review of non-medical publications recommending RYR for cholesterol management.
- Analysis of the active compound (monacolin K) in RYR and its comparison to pharmaceutical statins.
- Assessment of reported side effects, drug interactions, and contraindications, particularly during pregnancy.
- Evaluation of the current regulatory status and quality control of RYR products in the Netherlands.
Main Results:
- RYR is recommended for cholesterol reduction due to its monacolin K content.
- RYR may be better tolerated than statins, potentially due to lower average monacolin K dosages.
- Significant risks include potential drug interactions and adverse effects during pregnancy.
- There is a critical need for quality testing of RYR supplements and mandatory registration.
Conclusions:
- Consumers should select RYR products from reputable pharmaceutical companies and consult pharmacists for guidance.
- Awareness of potential drug interactions and risks, especially for pregnant individuals, is crucial.
- Urgent testing of RYR supplements by regulatory authorities and mandatory registration as herbal medicines are necessary to ensure product quality, consistent monacolin K levels, and consumer safety.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cholesterol: Significance and Regulation
Considering cholesterol and...
Atherosclerosis III: Management
Antihypertensive Drugs: Direct Renin Inhibitors
Experimental RNAi
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...

